-
Kenya's economy faces climate change risks: World Bank
-
US Fed expected to hold rates steady as Iran war's shockwaves ripple
-
Oscars audience drops, viewing figures show
-
Nvidia says restarting production of China-bound chips
-
US airlines still see strong demand as jet fuel worries loom
-
Milei blasts Iran on anniversary of attack on Israeli embassy
-
Leftist New York mayor under pressure on Irish unity question
-
Iran vets friendly ships for Hormuz passage: trackers
-
Ships in Gulf risk shortages on board, industry warns
-
New particle discovered by Large Hadron Collider
-
US Fed expected to keep rates steady as Iran war impact looms
-
Kerr 'frustrated' at six-figure sum owed to him by Johnson's failed Grand Slam Track
-
Oil prices climb as fresh strikes target infrastructure
-
Belgian diplomat ordered to stand trial over 1961 Congo leader murder
-
War threatens Gulf's dugongs, turtles and birds
-
Germany targets oil firms to prevent wartime price gouging
-
EU to help reopen blocked oil pipeline in Ukraine
-
Cash handouts, fare hikes as Philippines battles soaring fuel costs
-
Indonesia weighs response to price pressures from Middle East war
-
In Hollywood, AI's no match for creativity, say top executives
-
Nvidia chief expects revenue of $1 trillion through 2027
-
Nvidia making AI module for outer space
-
Migrant workers bear brunt of Iran attacks in Gulf
-
Trump vows to 'take' Cuba as island reels from oil embargo
-
Equities rise on oil easing, with focus on Iran war and central banks
-
Nvidia rides 'claw' craze with AI agent platform
-
Damaged Russian tanker has 700 tonnes of fuel on board: Moscow
-
Talks towards international panel to tackle 'inequality emergency' begin at UN
-
EU talks energy as oil price soars
-
Swiss government rejects proposal to limit immigration
-
Ingredients of life discovered in Ryugu asteroid samples
-
Why Iranian drones are hard to stop
-
France threatens to block funds for India over climate inaction
-
"So proud": Irish hometown hails Oscar winner Jessie Buckley
-
European bank battle heats up as UniCredit swoops for Commerzbank
-
Italian bank UniCredit makes bid for Germany's Commerzbank
-
AI to drive growth despite geopolitics, Taiwan's Foxconn says
-
Filipinas seek abortions online in largely Catholic nation
-
'One Battle After Another' wins best picture Oscar
-
South Koreans bask in Oscars triumph for 'KPop Demon Hunters'
-
'One Battle After Another' dominates Oscars
-
Norway's Oscar winner 'Sentimental Value': a failing father seeks redemption
-
Indonesia firms in palm oil fraud probe supplied fuel majors
-
Milan-Cortina Paralympics end as a 'beacon of unity'
-
It's 'Sinners' vs 'One Battle' as Oscars day arrives
-
Oscars night: latest developments
-
US Fed expected to hold rates steady as Iran war roils outlook
-
It's 'Sinners' v 'One Battle' as Oscars day arrives
-
US mayors push back against data center boom as AI backlash grows
-
Who covers AI business blunders? Some insurers cautiously step up
Google AI tool predicts danger of genetic mutations
Researchers at Google DeepMind, the tech giant's artificial intelligence arm, on Tuesday introduced a tool that predicts whether genetic mutations are likely to cause harm, a breakthrough that could help research into rare diseases.
The findings are "another step in recognising the impact that AI is having in the natural sciences," said Pushmeet Kohli, vice president for research at Google DeepMind.
The tool focuses on so-called "missense" mutations, where a single letter of the genetic code is affected.
A typical human has 9,000 such mutations throughout their genome; they can be harmless or cause diseases such as cystic fibrosis or cancer, or damage brain development.
To date, four million of these mutations have been observed in humans, but only two percent of them have been classified, either as disease-causing or benign.
In all, there are 71 million such possible mutations. The Google DeepMind tool, called AlphaMissense, reviewed these mutations and was able to predict 89 percent of them, with 90 percent accuracy.
A score was assigned to each mutation, indicating the risk of it causing disease (otherwise referred to as pathogenic).
The result: 57 percent were classified as probably benign, and 32 percent as probably pathogenic -- the remainder being uncertain.
The database was made public and available to scientists, and an accompanying study was published on Tuesday in the journal Science.
AlphaMissense demonstrates "superior performance" than previously available tools, wrote experts Joseph Marsh and Sarah Teichmann in an article also published in Science.
"We should emphasize that the predictions were never really trained or never really intended to be used for clinical diagnosis alone," said Jun Cheng of Google DeepMind.
"However, we do think that our predictions can potentially be helpful to increase the diagnosed rate of rare disease, and also potentially to help us find new disease-causing genes," Cheng added.
Indirectly, this could lead to the development of new treatments, the researchers said.
The tool was trained on the DNA of humans and closely-related primates, enabling it to recognize which genetic mutations are widespread.
Cheng said the training allowed the tool to input "millions of protein sequences and learns what a regular protein sequence looks like."
It then could identify a mutation and its potential for harm.
Cheng compared the process to learning a language.
"If we substitute a word from an English sentence, a person that is familiar with English can immediately see whether this word substitution will change the meaning of the sentence or not."
D.Philippon--CPN